Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors
Main Authors: | , , , , , , , , , |
---|---|
格式: | Conference item |
出版: |
Oxford University Press
2017
|
總結: |
---|